logo-loader
LSE:HEMO OTC:HOPHF

Hemogenyx Pharmaceuticals PLC

Receive alerts
Market:
LSE
Price
1.74 GBX
Day Change
-1.56%
Market Cap:
£23.35 m
52 weeks high
7.13
52 weeks low
1.10

In brief

Hemogenyx Pharmaceuticals PLC is a clinical-stage biopharmaceutical group developing new medicines and treatments for life-threatening diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Are small-cap biotech stocks good investments now?

We look at the sector's success stories and assess what we can expect in the coming months

on 14/8/20